larotrectinib,177lu-psma-618
novartis,bayer
['sclc', 'lu 177', 'nsclc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'larotrectinib']
what does ending cancer mean?
screen, diagnose early, and treat properly to decrease mortality!
innovative approvals! #gu23 #medtwitter 
On the road!
Pursuing to improve global health through sharing knowledge, cancer prevention, and care.  
Medical oncologist @AnkaraUni